Photo-Responsive Carrier for Hydrophobic Small Molecule Delivery at Target Site
- Drug Delivery
Key Problem and Market Opportunity
- Retinoblastoma is a severe eye cancer of infancy and childhood and can cause blindness or even death.
- Currently, the invasive intravitreal drug administration used in clinics is unpleasant for patients and can lead to side effects such as ocular haemorrhage, endophthalmitis and retinal detachment, etc.
- Thus, effective drug administration routes in a less invasive manner are desirable for the treatment of retinoblastoma.
Key Advantages of the Technology
- Three-legged small molecules are the main building blocks of the nanocarriers.
- The cleavage of the three-legged molecules upon light irradiation can quickly lead to the breakdown of the nanocarriers, resulting in the rapid release of the drugs only at the irradiated sites.
- On-demand drug delivery to achieve a less invasive and more efficient treatment
- Metal free
- Platform technology for delivering different drugs
Potential Product and Services
Target drug delivery system for eye or skin diseases
Development Status and IP Strength
- PCT Application No. PCT/CN2021/081262
- Patent application submitted